Caris Life Sciences President David Baxley Spetzler disposes of USD 14.75 million in common shares

• Caris Life Sciences President David Baxley Spetzler sold 597,212 shares on Sept. 3–4 at about $24.76–$25.32.
• Transactions followed stock option exercises of 1,250,000 shares at $2.44.
• Beneficial ownership ended at 1,182,871 shares of common stock.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002071953-26-000007), on September 04, 2026, and is solely responsible for the information contained therein.